Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Busquets Figueras, Oriol et al., 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/151078

Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Previous studies have reported that the regulatory function of the different c-Jun N-terminal kinases isoforms (JNK1, JNK2, and JNK3) play an essential role in neurological disorders, such as epilepsy and metabolic-cognitive alterations. Accordingly, JNKs have emerged as suitable therapeutic strategies. In fact, it has been demonstrated that some unspecific JNK inhibitors exert antidiabetic and neuroprotective effects, albeit they usually show high toxicity or lack therapeutic value. In this sense, natural specific JNK inhibitors, such as Licochalcone A, are promising candidates. Nonetheless, research on the understanding of the role of each of the JNKs remains mandatory in order to progress on the identification of new selective JNK isoform inhibitors. In the present review, a summary on the current gathered data on the role of JNKs in pathology is presented, as well as a discussion on their potential role in pathologies like epilepsy and metabolic-cognitive injury. Moreover, data on the effects of synthetic small molecule inhibitors that modulate JNK-dependent pathways in the brain and peripheral tissues is reviewed.

Citation

Citation

BUSQUETS FIGUERAS, Oriol, et al. Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment. International Journal of Molecular Sciences. 2019. Vol. 21, num. 1, pags. 255. ISSN 1661-6596. [consulted: 9 of June of 2026]. Available at: https://hdl.handle.net/2445/151078

Export metadata

JSON - METS

Share record